Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
S
Shree Ganesh Remedies Ltd
Score 48/100• Decent
Shree Ganesh Remedies Ltd shows potential in a future-ready sector, but faces challenges in growth consistency and market sentiment.
Company’s Health97/100
Valuation 40/100 · PB 4.3865
Technical Avoid
1M -2.744% 6M -32.388% 1Y -37.587%
Confidence100%
Low leverage (D/E)No promoter pledge
#181
View details ➜
S
Saroja Pharma Industries India Ltd
Score 48/100• Risky
Saroja Pharma Industries presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health69/100
Valuation 80/100 · PB 1.1064
Technical Avoid
1M -1.259% 6M 11.643% 1Y -18.354%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#182
View details ➜
S
Sanofi Consumer Healthcare India Ltd
Score 48/100• Decent
Sanofi Consumer Healthcare India Ltd shows potential but faces challenges in profitability and execution risks.
Company’s Health100/100
Valuation 20/100 · PB 40.8528
Technical Avoid
1M -3.026% 6M -1.964% 1Y -1.666%
Confidence100%
Low leverage (D/E)No promoter pledge
#183
View details ➜
M
Marksans Pharma Ltd
Score 48/100• Decent
Marksans Pharma Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
Company’s Health90/100
Valuation 40/100 · PB 3.3145
Technical Avoid
1M 11.758% 6M -18.441% 1Y -37.138%
Confidence100%
Low leverage (D/E)No promoter pledge
#184
View details ➜
L
Link Pharmachem Ltd
Score 48/100• Risky
Link Pharmachem Ltd presents a risky investment opportunity due to inconsistent growth, profitability concerns, and high valuation metrics compared to peers.
Company’s Health46/100
Valuation 80/100 · PB 1.2276
Technical Avoid
1M -18.663% 6M -1.13% 1Y -15.764%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#185
View details ➜
L
Lincoln Pharmaceuticals Ltd
Score 48/100• Decent
Lincoln Pharmaceuticals shows potential but faces challenges in profitability and market sentiment.
Company’s Health83/100
Valuation 80/100 · PB 1.5799
Technical Avoid
1M 0.264% 6M -7.507% 1Y -22.065%
Confidence100%
Low leverage (D/E)No promoter pledge
#186
View details ➜
I
Influx Healthtech Ltd
Score 48/100• Risky
Influx Healthtech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health100/100
Valuation 20/100 · PB 11.9722
Technical Momentum
1M 7.852% 6M 48.138% 1Y 48.138%
Confidence100%
Low leverage (D/E)No promoter pledge
#187
View details ➜
R
Rajnish Wellness Ltd
Score 48/100• Risky
Rajnish Wellness Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health54/100
Valuation 80/100 · PB 1.0014
Technical Avoid
1M -9.677% 6M -13.468% 1Y -64.325%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#188
View details ➜
R
Raaj Medisafe India Ltd
Score 48/100• Risky
The stock presents significant risks with inconsistent growth and profitability metrics, alongside governance concerns.
Company’s Health84/100
Valuation 40/100 · PB 3.6546
Technical Avoid
1M 19.409% 6M 9.035% 1Y -21.654%
Confidence100%
No promoter pledgeDecent revenue growth
#189
View details ➜
Q
Qualitek Labs Ltd
Score 48/100• Risky
Qualitek Labs Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health92/100
Valuation 20/100 · PB 5.3369
Technical Watch
1M 3.073% 6M 34.707% 1Y 54.517%
Confidence100%
No promoter pledge
#190
View details ➜
Q
QMS Medical Allied Services Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health91/100
Valuation 80/100 · PB 1.8056
Technical Avoid
1M 3.87% 6M 16.331% 1Y -6.342%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#191
View details ➜
M
Mohini Health & Hygiene Ltd
Score 48/100• Risky
Mohini Health & Hygiene Ltd presents several risks, particularly in profitability and market sentiment, making it a risky investment at this time.
Company’s Health63/100
Valuation 100/100 · PB 0.8226
Technical Avoid
1M -3.596% 6M -21.951% 1Y -8.571%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#192
View details ➜
M
Maitreya Medicare Ltd
Score 48/100• Risky
Maitreya Medicare Ltd shows potential in a growing sector, but significant risks and inconsistencies in performance make it a risky investment.
Company’s Health74/100
Valuation 40/100 · PB 4.8866
Technical Avoid
1M 5.952% 6M -21.426% 1Y -31.896%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#193
View details ➜
K
Kopran Ltd
Score 48/100• Risky
Kopran Ltd operates in a promising sector but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
Company’s Health73/100
Valuation 80/100 · PB 1.5405
Technical Avoid
1M -4.921% 6M -13.036% 1Y -42.41%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#194
View details ➜
K
KOBO Biotech Ltd
Score 48/100• Risky
KOBO Biotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health41/100
Valuation 100/100 · PB -0.0525
Technical Avoid
1M 30.396% 6M 3.333% 1Y 5.085%
Confidence100%
No promoter pledgeReasonable PB valuation
Thin margins
#195
View details ➜
Showing 181 to 195 of 260 (18 Pages)